Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | VEL | GEMI |
|---|---|---|
| Price | $14.74 | $4.49 |
| Change today | ▼ 0.87% | ▼ 3.85% |
| Market cap | $581.96M | $582.14M |
| Return, 3 months | -16.3% | +5.6% |
| Return, year to date | -29.0% | -54.7% |
| Return, 1 year | -18.7% | -82.5% |
| P/E (TTM) | 5.3 | -1.1 |
| P/B | 0.8 | 1.2 |
| P/E percentile vs own 5y | 0th | 58th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +1.1% | +36.6% |
| Net profit growth (YoY) | -1.7% | +19.1% |
| Gross margin | – | -70.3% |
| Operating margin | – | -195.1% |
| Net margin | 32.4% | -250.1% |
| Return on equity | 16.1% | – |
| Analyst target vs. price | +35.7% | +15.6% |
| Analyst buy share | 100% | 33% |
| RSI (14) | 24 | 43 |
| 30-day volatility | 24.3% | 114.6% |
| Max drawdown, 1 year | -29.7% | -86.2% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
